1
Furthermore, female mice exhibited elevated cytotoxic T lymphocyte responses and immune memory.
2
SIV-specific cytotoxic T lymphocytes were detected in two of the four monkeys.
3
However, while antibody responses fell with time, cytotoxic T-cell responses persisted.
4
They activate the immune system by promoting cytotoxic T-cell survival and antitumor effects.
5
Conclusions: Tumor-specific cytotoxic T lymphocytes can be expanded from both TAL and TIL.
6
In addition, cytotoxic T lymphocytes recognizing these epitopes were found in HIV-infected patients.
7
The temporal appearance of cytotoxic T cells was similar to that of antibody.
8
Wild-type cytotoxic T lymphocytes persisted even after the cognate antigen was no longer present.
9
CAFs also reduced the number and activation of tumor-infiltrating cytotoxic T-cell in tumor tissue.
10
Increased cytotoxic T lymphocyte responses were observed in all groups.
11
These include viruses, autoimmune antibodies and autoimmune cytotoxic T lymphocytes.
12
Tumor-specific cytotoxic T lymphocytes could be generated from tumor-rejected mice.
13
Background: Hepatitis B virus-infected cells can be eliminated by the cytotoxic T cell-mediated immune reaction.
14
In vivo, this could eventually lead to the exhaustion of the cytotoxic T cell compartment.
15
Langerhans cells in human skin seem to be specialized for induction of cytotoxic T lymphocytes.
16
Adoptive transfer of antigen-specific cytotoxic T lymphocytes has shown promise for the therapy of cancer.
